Target intelligence / Profile preview

B-cell lymphoma-w protein (None)

Target
None
Molecular classification
Anti-apoptotic protein, Bcl-2 family
01

Overview

The B-cell lymphoma-w protein (BCL-W) is a member of the BCL-2 family, a key regulator of apoptosis. BCL-W acts as an antiapoptotic factor promoting cell survival by inhibiting programmed cell death. Overexpression is observed in lymphomas such as Burkitt Lymphoma and Diffuse Large B Cell Lymphoma, which correlates with decreased patient survival rates and resistance against therapies targeting other antiapoptotic members. MYC regulates expression levels. Potential therapeutic strategies aim at inhibiting or downregulating BCL-W to sensitize tumor cells to apoptosis-inducing treatments.

Other names
Bcl-w
02

Mechanism of action

Currently no widely available direct inhibitors; research focuses on developing strategies to inhibit or downregulate BCL-W

03

Biological functions

Inhibition of apoptosisCell survival
04

Disease associations

CancerLymphoma (Burkitt Lymphoma, Diffuse Large B Cell Lymphoma)Tumorigenesis
05

Safety considerations

Inhibition may disrupt normal cell survival mechanismsPotential for off-target effects
06

Biomarkers

Elevated BCL-W levels in Burkitt Lymphoma and Diffuse Large B Cell Lymphoma

Beyond the preview

Go deeper on B-cell lymphoma-w protein (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell lymphoma-w protein (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call